$INTS
INTENSITY THERAPEUTICS, INC.
CIK:0001567264|SEC Filings
CONDENSED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Operating expenses: | ||||
| Research and development | $ 1,833 | $ 1,541 | $ 3,028 | $ 3,730 |
| General and administrative | 1,251 | 1,164 | 2,582 | 2,369 |
| Total operating expenses | 3,084 | 2,705 | 5,610 | 6,099 |
| Loss from operations | (3,084) | (2,705) | (5,610) | (6,099) |
| Other income (expense): | ||||
| Interest income | 77 | 17 | 171 | 33 |
| Other (expense) income, net | 0 | 151 | (2) | 182 |
| Net loss | $ (3,007) | $ (2,537) | $ (5,441) | $ (5,884) |
| Loss per share, basic (in dollars per share) | $ (1.11) | $ (3.36) | $ (2.08) | $ (8.64) |
| Loss per share, diluted (in dollars per share) | $ (1.11) | $ (3.36) | $ (2.08) | $ (8.64) |
| Weighted average number of shares of common stock, basic (in shares) | 2,706,607 | 754,725 | 2,620,740 | 681,235 |
| Weighted average number of shares of common stock, diluted (in shares) | 2,706,607 | 754,725 | 2,620,740 | 681,235 |